Related Experiment Video
Updated: May 27, 2025
A Porcine Model of Acute Autologous Pulmonary Embolism
Published on: September 6, 2024
Clinical characteristics and prognosis of patients with central pulmonary embolism
Robin V Hofstetter1, Odile Stalder2, Tobias Tritschler1
1Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
Background:
The impact of central localization of pulmonary embolism (PE) on clinical outcomes is uncertain.
Objectives:
To compare clinical presentation, risk factors, and outcomes between patients with central pulmonary embolism (cPE) and non-cPE.
Methods:
We retrospectively analyzed 597 patients with acute PE from the prospective SWITCO65+ cohort between September 2009 and December, 2013. cPE was defined as an embolus in the pulmonary trunk or the left or right pulmonary artery. We compared baseline clinical characteristics and outcomes at 3 months (recurrent venous thromboembolism [VTE], overall/PE-related mortality, PE-related quality of life) and over the entire follow-up (recurrent VTE, overall/PE-related mortality) between patients with cPE vs non-cPE. We examined the association between PE localization and recurrent VTE and overall mortality, adjusting for multiple confounders including thrombolysis, periods of anticoagulation, and competing risk of non-VTE-related death if appropriate.
Results:
Overall, 217 (36.3%) patients had cPE. Symptoms/signs of respiratory distress, right ventricular dysfunction, and myocardial injury were more prevalent in those with cPE. VTE recurrence, overall/PE-related mortality, and PE-related quality of life at 3 months did not vary by PE localization. After a median follow-up of 29.6 months, patients with cPE had a higher risk of fatal PE (5.5% vs 2.1%; P = .033). After adjustment, cPE was associated with recurrent VTE (subhazard ratio, 2.22; 95% CI, 1.25-3.91) but not with overall mortality (hazard ratio, 0.74; 95% CI, 0.45-1.21) during follow-up.
Conclusion:
cPE was associated with a 2.2-fold increased risk of recurrent VTE compared to non-cPE. Whether an extended anticoagulation duration could reduce the recurrence risk following cPE should be further examined.
Related Concept Videos
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:27Pneumothorax-II
Clinical Manifestations:
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
01:28Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations: